Frankfurt - Delayed Quote EUR

J Frontier Co.,Ltd. (R0L.F)

18.20 0.00 (0.00%)
At close: April 16 at 3:29 PM GMT+2
Key Events
Loading Chart for R0L.F
DELL
  • Previous Close 18.20
  • Open 18.30
  • Bid 13.90 x --
  • Ask 14.60 x --
  • Day's Range 18.20 - 18.30
  • 52 Week Range 16.10 - 30.70
  • Volume 100
  • Avg. Volume 0
  • Market Cap (intraday) 89.797M
  • Beta (5Y Monthly) 0.68
  • PE Ratio (TTM) --
  • EPS (TTM) -2.17
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

J Frontier Co.,Ltd. engages in the healthcare sale, medical care sale, and healthcare marketing businesses in Japan. It is involved in various activities, including online medical care, medication guidance, as well as operates drug delivery platform, medical institutions, and operates dispensing pharmacy. The company engages in distribution of pharmaceuticals products as well as involved in marketing, logistics, and call center activities. J Frontier Co.,Ltd. was incorporated in 2008 and is based in Tokyo, Japan.

jfrontier.jp

255

Full Time Employees

May 31

Fiscal Year Ends

Related News

Performance Overview: R0L.F

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

R0L.F
32.09%
Nikkei 225
13.36%

1-Year Return

R0L.F
--
Nikkei 225
16.74%

3-Year Return

R0L.F
--
Nikkei 225
16.74%

5-Year Return

R0L.F
--
Nikkei 225
16.74%

Compare To: R0L.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: R0L.F

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    70.97M

  • Enterprise Value

    82.82M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.88

  • Price/Book (mrq)

    5.44

  • Enterprise Value/Revenue

    0.00

  • Enterprise Value/EBITDA

    -0.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.06%

  • Return on Assets (ttm)

    -11.08%

  • Return on Equity (ttm)

    -49.04%

  • Revenue (ttm)

    17.01B

  • Net Income Avi to Common (ttm)

    -1.71B

  • Diluted EPS (ttm)

    -2.17

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.18B

  • Total Debt/Equity (mrq)

    105.26%

  • Levered Free Cash Flow (ttm)

    --

Company Insights: R0L.F